Aclaris Therapeutics Inc
NASDAQ:ACRS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aclaris Therapeutics Inc
NASDAQ:ACRS
|
US |
|
Clean Energy Fuels Corp
NASDAQ:CLNE
|
US |
|
N
|
Narnia (Hong Kong) Group Co Ltd
HKEX:8607
|
CN |
|
Asensus Surgical Inc
F:2TX
|
US |
|
Bouvet ASA
OSE:BOUV
|
NO |
|
P
|
PC Direct Inc
KOSDAQ:051380
|
KR |
|
Banco Comercial Portugues SA
ELI:BCP
|
PT |
|
SMC Corp
OTC:SMECF
|
JP |
|
Adux SA
PAR:ADUX
|
FR |
|
S
|
Spirit Blockchain Capital Inc
CNSX:SPIR
|
CA |
|
Mestek Inc
OTC:MCCK
|
US |
Intrinsic Value
The
intrinsic value for
Aclaris Therapeutics Inc (ACRS)
under the Base Case is
hidden
USD.
Compared with the current market price of 3.93 USD, the stock appears
hidden
.
ACRS looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether ACRS usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Aclaris Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Aclaris Therapeutics Inc
Earnings Waterfall
Aclaris Therapeutics Inc
The
intrinsic value for
Aclaris Therapeutics Inc (ACRS)
under the Base Case is
hidden
USD.
Compared with the current market price of 3.93 USD, the stock appears hidden .